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The Gene Ontology Consortium (GOC) is a major bioinformatics project that provides structured controlled
vocabularies to classify gene product function and location. GOC members create annotations to gene products
using the Gene Ontology (GO) vocabularies, thus providing an extensive, publicly available resource. The GO and its
annotations to gene products are now an integral part of functional analysis, and statistical tests using GO data are
becoming routine for researchers to include when publishing functional information. While many helpful articles
about the GOC are available, there are certain updates to the ontology and annotation sets that sometimes go
unobserved. Here we describe some of the ways in which GO can change that should be carefully considered by
all users of GO as they may have a significant impact on the resulting gene product annotations, and therefore the
functional description of the gene product, or the interpretation of analyses performed on GO datasets. GO
annotations for gene products change for many reasons, and while these changes generally improve the accuracy
of the representation of the underlying biology, they do not necessarily imply that previous annotations were
incorrect. We additionally describe the quality assurance mechanisms we employ to improve the accuracy of
annotations, which necessarily changes the composition of the annotation sets we provide. We use the Universal
Protein Resource (UniProt) for illustrative purposes of how the GO Consortium, as a whole, manages these changes.
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Since its initial publication in 2000 [1] over 5,000 peer-
reviewed articles have cited the Gene Ontology (GO)a,
and each year an increasing number of researchers are
using GO to assist them in informing or validating their
hypotheses. GO is used both for small- and large-scale
applications, for example, providing functional data for a
single protein or a GO term enrichment analysis for an
entire proteome, as well as by researchers analyzing the
changes in GO itself over time and measuring the reli-
ability and comprehensiveness of GO annotations [2].
With this increasing usage, it is imperative that users
of GO are well informed as to how GO and its associa-
tions to gene products (GO annotations) are created and
maintained. Several helpful articles have been published
that describe the work of the GO Consortium (GOC)
[3-8], but there are certain changes to the ontology and* Correspondence: huntley@ebi.ac.uk
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unless otherwise stated.annotation sets that are less widely known among users
of the GO.
GO provides almost 40,000 terms across three ontologies
describing biological attributes of gene products (October
2013). This includes the 1) molecular functions a gene
product performs, 2) the biological processes it is involved
in and 3) the cellular components it is located in; each one
of these terms may be associated with any number of gene
products. These associations are known as ‘annotations’
and can be created either manually or automatically. Man-
ual annotations are made by a curator reading full-text pri-
mary literature and capturing functional data [4]. Manual
annotations provide detailed and specific information and
are critical for creating learning sets for automated pipe-
lines. Automatic annotations are made using algorithms
that consider gene product properties, such as orthology,
domains and sequence similarity [5,9], and they provide a
broad coverage of annotation and cover a significantly lar-
ger taxonomic range than manual annotations. This differ-
ence in coverage is illustrated by the annotation statistics
from the database of the UniProt GO Annotation projectl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the GOC members [5]; as of November 2013, GOC pro-
vides over 200 million annotations, with around 99% of
these being automatically created [10,11].
Many changes are made to both the ontology and anno-
tation sets over time - some of these changes are planned
and announced by GOC or its members via mailing lists
or release notes [10,12], whereas others are not and reflect
ongoing improvements, such as user requests for updates
to the ontology [13] or annotations [14], as well as revi-
sions in response to quality assurance checks.
Here we will cover some of the types of changes that
can occur on a regular basis and give examples of un-
planned changes that have happened in the past. We will
also describe the quality assurance mechanisms we have
in place, which are available to any group generating GO
annotation, and which can be used to improve the accur-
acy of both manual and automatic annotations, inevitably
changing the composition of GO annotation datasets.
Review
Changes to ontologies and annotations
One of the major misconceptions about GO is that the on-
tologies and annotations give a complete coverage of bio-
logical knowledge and are therefore stable and unchanging.
This is not the case, partly because biological knowledge
itself is incomplete and partly because of the large volume
of experimental evidence that has yet to be captured by
functional annotation. Changes to both the ontology and
annotations are frequent; the revisions and additions that
are made to the ontology are publicly released by the GOC
each day and those to the UniProt GO annotation dataset
every week. At its most complete, GO can only ever reflect
what is currently known and there are parts of biology that
are not represented in GO as well as they could be. In the
case of the ontologies, these parts are being identified and
progressively improved by collaborations between expert
scientists and the GOC to accurately represent specific
areas of biology. These changes to the GO also involve a
subsequent effort to assign the new terms to gene prod-
ucts, thereby affecting the composition of annotation sets,
in terms of both adding and removing annotations. It
should be said, however, that the fact that an association
between a gene product and a particular GO term may be
removed does not necessarily imply the annotation was in-
correct. Here we will describe several reasons why GO
terms and annotations may change over time.
Development of the ontologies
The ontologies need to be refined constantly in order to
keep up with the latest biological knowledge and to inter-
sect appropriately with other ontologies. The priorities for
development are decided based on the particular interests
and expertise of GOC members, funding from externalbodies to develop a certain area of the ontology, as well as
addressing inconsistencies in the GO. It must be noted
that any change to the ontology is carefully considered,
and discussed with experts if necessary, to avoid introdu-
cing inconsistencies or incorrect information. The ontol-
ogy request tracker [13] is a publicly available tool for
users to request and follow updates to the ontology,
and terms affected by a current ontology development
project are highlighted in the “GO Discussions” section
of the term page in the UniProt-developed GO browser
QuickGO [15].
The alterations may involve only small-scale changes to
update a definition or add parent or child terms, or it may
be a more comprehensive project involving experts in the
scientific community to assist a larger restructuring of
specific parts of the ontologies. Some examples of this
large-scale ontology development that have been done re-
cently include the restructuring and supplementation of
the GO terms referring to heart [16] and kidney [17] de-
velopment, apoptosis [Paola Roncaglia et al., personal
communication] and the cell cycle [Valerie Wood et al.,
personal communication].
If we look at the term ‘apoptotic process’ (GO:0006915),
we can see how this re-structuring can impact both the
ontologies and annotations (Figure 1). During its lifetime,
this term has been edited 54 times so far. Most of these
are simple changes such as additional synonyms, but there
are also refinements to the definition to clarify the scope
of the term in response to the experimental knowledge
gained over time about this complex process. The restruc-
turing of the apoptosis node in GO resulted in several
new, more specific terms and therefore, a re-annotation
effort was necessary to reflect the current experimental
knowledge in this area. During the re-annotation exercise,
annotations were moved to more descriptive terms that
were not available at the time of the original annota-
tion; for example ‘positive regulation of extrinsic apop-
totic signaling pathway via death domain receptors’
(GO:1902043). It is important that users are aware of the
regular work the GOC does to improve the annotation of
gene products in a certain area of biology because when
an annotation is moved to a more granular term, it could
be interpreted that the annotation to the less granular
term was removed because it was incorrect, when in fact
it was an appropriate annotation, but a more specific one
could be made instead. The less granular annotation was
correct because the GO adheres to the “true-path-rule”,
which means that if a gene product is annotated to a given
term, it must also be the case that it can be correctly de-
scribed by all of the ancestors of that term. The introduc-
tion of more detailed GO terms, and the subsequent use
of these terms for curating gene products, allows the user
to identify very specifically the functional role(s) of their
proteins of interest.
Figure 1 Changes to the “apoptotic process” term. The most recent changes to the GO term “apoptotic process” as displayed in QuickGO [20].
In total there have been 54 changes over the lifetime of the term.
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In addition to updating the ontology terms themselves,
changes to relationships between the terms can also have a
significant impact on annotations. In November 2011, there
was a decrease of ~2,500 manually and automatically
assigned annotations to the Biological Process term ‘tran-
scription, DNA-dependent’ (GO:0006351; 18% of total GO
Consortium inferred annotations: data from UniProt-GOA
releases 101 and 100) due to the removal of an inter-
ontology link between this term and the Molecular Function
term ‘sequence-specific DNA binding transcription factor
activity’ (GO:0003700). Inter-ontology links are provided
when a function is always found to be part of a process, or a
process always occurs in a specific subcellular location; these
are used to create inferred annotations to Biological Process
or Cellular Component terms when a linked Molecular
Function or Biological Process term has been annotated, re-
spectively. In the example given, it was determined that gene
products involved in sequence-specific DNA binding tran-
scription factor activity are not always directly involved in
DNA-dependent transcription and so the link was removed,
resulting in the removal of annotations inferred from this
ontology link.
Obsoleting terms from the ontologies
In addition to adding new GO terms and refining existing
ones, there is occasionally the need to make obsoleteterms that are now considered out-of-scope for GO, for
example, those that describe gene products or temporal
events. When terms have been identified for obsoletion,
quite often a replacement or suggested term is given, for
example the Molecular Function term ‘apoptosis inhibitor
activity’ (GO:0008189) was obsoleted because it was actu-
ally describing a Biological Process, and it was therefore
replaced by the term ‘negative regulation of apoptotic
process’ (GO:0043066), meaning any gene products that
were associated with the former term are also appropri-
ately described by the latter term. When providing re-
placement terms, the existing annotations are carefully
reviewed to ensure that incorrect annotations will not be
introduced. Curators are alerted to any change that may
cause problems and are asked to re-annotate to a more
appropriate term. Consequently, these refinements can
have a significant impact on annotations in terms of
numbers, that is, annotations using a term that is now
obsolete will be removed and potentially replaced by a
more appropriate term, but also an increase in accuracy
of the resulting annotations.
Identifying ontology terms unsuitable for direct annotation
Since 2012, GO has started designating some GO terms
as not acceptable for direct annotation (direct annotation
here means the use of the GO term as the primary anno-
tation for a gene product). These terms remain in the GO
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applications.
There are two such subsets of terms:
1. Those that are inappropriate for both manual and
automatic annotation, for example, ‘nuclear part’
(GO:0044428) or ‘S phase’ (GO:0051320) [18]. The
‘Cellular Component-part’ terms are present only for
ontology completeness, whereas the cell-cycle phase
terms describe a time period rather than a specific
process, but remain in the Biological Process ontology
as they are used in other parts of an annotation, such
as annotation extensions [4], but cannot be used to
directly associate to a gene product. For annotations
that are associated with a term from this subset, it
should always be possible to associate the gene product
with an alternative term, for example, gene products
associated with ‘nuclear part’ (GO:0044428) are more
appropriately associated with the ‘nucleus’ term
(GO:0005634).
2. Those that are inappropriate for manual annotation,
but automatic annotation is acceptable (e.g. ‘response
to stress’ [GO:0006950]) [19]. These terms are
considered too general to be useful. In all cases, there
should be a more specific term that the gene product
should be associated with, for example, a paper
describing a gene product’s involvement in a stress
response should always detail the type of stress
applied, allowing the curator to choose a more
specific child term of ‘response to stress’
(GO:0006950). Predictions made by automatic
annotation methods use these terms as it may not be
possible to choose a more specific term that will
always be true for all gene products annotated by the
prediction method.
Terms in these subsets are identified by a “Restriction”
comment in the UniProt-developed GO browser QuickGO
[20] alerting curators not to use them.
Adding annotations using the ontologies
Subsequent to the ontology developments for heart [16]
and kidney [17] development, and apoptosis that were de-
scribed earlier, curators made use of the revised and ex-
panded ontologies to improve the annotation of gene
products. In the case of the heart development annotation
project, this has so far resulted in almost 30,000 annota-
tions being provided for 4,000 proteins (data from
UniProt-GOA release 124). The added value of these new
annotations has previously been demonstrated by per-
forming GO term enrichment analyses on annotation sets
from before and after the curation project. The analysis of
the annotations after the curation effort provided terms
with an increased depth and specificity compared with theanalysis before the curation effort, thereby improving the
interpretation of analyses of large datasets [21,22].
Curators not only provide annotation following ontol-
ogy development, but also take part in focused annotation
of gene products independent of ontology development.
As increasing amounts of published experimental evi-
dence has yet to be captured by functional annotation,
prioritization of gene products for curation is important
to consider. UniProt prioritizes annotation based on the
expected benefit to the larger scientific community and
has had proven success when curating proteins involved
in specific organ development [17,21] or location in a spe-
cific organelle [23]. This latter project involved the cur-
ation of all known roles and locations of human proteins
that are found in the peroxisome. During the course of
the curation, 49 new peroxisome-related terms were iden-
tified for addition to the ontologies, highlighting that an
important role of the curator is to identify and request the
creation of terms missing from GO. The project resulted
in 1,551 annotations being created for 88 peroxisomal
proteins, as well as 296 non-peroxisomal proteins where
functional data was available in the same publications as
the peroxisomal proteins [23]. This work additionally
demonstrated an increased depth and specificity of
enriched GO terms in a term enrichment analysis.
Changes to the reference of annotations
All GO annotations require a reference or authority de-
scribing where the evidence for the annotation originated,
such as a PubMed identifier or an abstract where a descrip-
tion of how the annotation was made is provided. The lat-
ter are termed “GO references” [24]. In the process of
refining annotation sets, it has very occasionally become
necessary to change the reference for a set of annotations
in order to better describe the origin of the annotations.
There were two such cases at the beginning of 2013
when it became necessary to change the reference associ-
ated with a large set of manually created Cellular Compo-
nent annotations provided by the Human Protein Atlas
and LifeDB projects [25,26]. Previously these annotations
were referenced by publications describing the experimen-
tal methods used in pilot studies for obtaining the annota-
tions. As such, these publications did not actually contain
the experimental data for all of the gene product subcellu-
lar localizations that were referenced by them. As this left
the annotations open for misinterpretation [27], it was de-
cided that they would be more correctly described using a
GO reference. This kind of change is important for users
to be aware of since any analysis that makes use of the ref-
erence field of an annotation will have registered a large
decrease in the number of annotations, and has
prompted some researchers to mistakenly assume these
annotations were incorrect. When substantial changes
such as these are made in the UniProt annotation files,
Table 1 Examples of taxonomic groups whose only source
of annotation is from automatic prediction methods
Common name Taxon ID No. annotations
Viruses
Simian immunodeficiency virus 11723 202000
Dengue virus type 1 11053 82000
Vertebrates
West Indian ocean coelacanth 7897 76000
Black flying fox 9402 66000
Plants
Wild banana 214687 82000
Brachypodium distachyon 15368 75000
Insects
Monarch butterfly 13037 36000
Parasitic wasp 7425 35000
Bacteria
Ralstonia solanacearum 305 200000
Protozoans
Paramecium tetraurelia 5888 66000
Fungi
Penicillium stipitatum 441959 35000
This information was obtained by querying the UniProt-GOA database
(October 2013).
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panying file release notes, and we encourage users and
researchers to read them to ensure that their subse-
quent analyses benefit [10].
Changes in submitted annotation sets
In addition to the planned changes described above, there
may be problems with the data supplied by contributing
annotation groups that may result in large changes in the
number of annotations we import from these external da-
tabases. This can be due to a variety of reasons, for ex-
ample in April 2013 Ensembl Plants suspended GO
annotation for some species whilst they introduced taxon
constraints into their annotation pipeline. This resulted in
the omission of approximately 125,000 automatic annota-
tions from release 119 of the UniProt GO annotation file,
and the GO annotations for these species were not avail-
able again until release 122 (July 2013), after Ensembl
Plants resumed their GO annotation.
Large changes in annotation numbers can also occur
when annotating groups update their files that map be-
tween their gene product identifiers and UniProtKB acces-
sions. In January 2012, the Zebrafish Model Organism
Database updated their identifier mapping file resulting in
a decrease of approximately 15,000 manual annotations to
zebrafish proteins in release 104 of the UniProt GO anno-
tation file; in November 2011 a similar update to the Rat
Genome Database identifier mapping file was responsible
for a loss of approximately 20,000 manual annotations to
rat proteins (release 100 of the UniProt file).
Given the many changes and updates to the ontologies
and annotations described here, no single annotation file
can be considered as definitive. It is therefore recom-
mended that if a user wishes to use specific annotation
files for analyses, it is first worth checking with the pro-
vider of the file to determine if there are any significant
changes to the datasets that should be considered.
Quality assurance
Around 99% of GO annotation in the UniProt-GOA data-
base consist of automatic predictions. This type of annota-
tion is critical for supplying functional information to a
wide range of species that do not have experimental data
or a dedicated manual annotation focus. There are ap-
proximately 31 million proteins spanning 434,561 taxa
(October 2013) where the only source of GO annotation
is from automatic methods, some examples of which are
shown in Table 1. When comparing this with the approxi-
mately 264,000 proteins over 2,800 taxa that additionally
have manual annotation, it is clear that automatic annota-
tion is a very powerful method of populating large num-
bers of proteins with annotations in a short amount of
time. However we also need to ensure that annotations
from these large-scale automatic methods, as well as themanual annotations made by curators, are appropriate
and accurate for the species being annotated.
In addition to the ongoing work to improve existing
annotations as described in previous sections, specific
taxon-related quality control mechanisms have been de-
veloped that can prevent unsuitable annotations from
being created in the first place. A description of two of
these follows.
Taxon constraints
GO terms are generally defined to be taxon neutral, but
some are applicable only to certain taxa. In 2010, the
GOC started applying taxon restrictions to certain GO
terms. These restrictions improve the accuracy of anno-
tations as well as identifying errors in the ontologies
when applied as an automated check of GO term:taxon
combinations. In the initial implementation of the taxon
restrictions, approximately 1.6 million erroneous annota-
tions were found and corrected [28]. One example of an
improvement to GO, resulting from taxon restrictions,
was the refinement of the definitions for the terms con-
cerning microtubule organizing centers (MTOC). In
fungi, the MTOC is called the spindle pole body, whilst
in mammals it is called the centrosome. In GO we have
terms for ‘centrosome organization’ (GO:0051297) and
for ‘spindle pole body organization’ (GO:0051300); only
fungal gene products should be annotated to the ‘spindle
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the definitions of these terms were clarified so that the
meaning is more apparent for curators and users.
The taxon restrictions are publicly available [29,30] and
here we explain how to use these effectively. There are
currently two types of taxon restrictions; ‘only_in_taxon’
or ‘never_in_taxon’ and a term can have more than one
taxon constraint. It is important to understand that the
taxon restrictions are inherited by any child terms of the
term they are applied to. For this reason, the taxon restric-
tions must be used in conjunction with the GO and a tax-
onomy hierarchy.
For example the term ‘flower development’ (GO:0009908)
is covered by four taxon restrictions as shown in Figure 2.
Only one of these is applied directly to the term itself
(flower development can be found only_in_taxon
Magnoliophyta), the other three restrictions are inher-
ited from the parent term ‘multicellular organismal
process’ (GO:0032501).
Although those annotations that violate a taxon restric-
tion could be removed upon import of the annotations
into the UniProt-GOA database, it is always optimal to ad-
dress the problem at source and ensure that the error is
not propagated further. UniProt has been actively working
with InterPro, who provide 49% of total GO annotations
in the UniProt-GOA database, to assist them in refining
the mapping between InterPro identifiers and GO terms,
thereby reducing the number of InterPro GO annotations
with taxon violations. In many cases, this refinement in-
volved choosing a GO term for the mapping that is furtherFigure 2 Taxon restrictions for the term “flower development”. This term ha
These restrictions can prevent GO terms from being used inappropriately for certaup the hierarchy and is less restrictive with respect to the
taxonomic groups it can be used with. This will ensure
the predicted annotation is correct over a larger number of
gene products. Figure 3 shows an example of how a GO
term, in this case ‘mitochondrial fatty acid beta-oxidation
multienzyme complex’ (GO:0016507), which provides
quite specific information, has more taxon restrictions than
the less specific term ‘fatty acid beta-oxidation multien-
zyme complex’ (GO:0036125). The InterPro entry
IPR012799, which contains matches to Eukaryotic and bac-
terial proteins, was originally mapped to ‘mitochondrial
fatty acid beta-oxidation multienzyme complex’ (GO:00
16507) causing the bacterial proteins to be mis-annotated.
Choosing the parent term ‘fatty acid beta-oxidation multi-
enzyme complex’ (GO:0036125) for mapping to GO will
result in more accurate annotation for the entire set of pro-
tein matches.
Groups providing UniProt with annotations (e.g.,
InterPro, Ensembl and Ensembl Genomes) are starting
to use these taxon restrictions when creating their annota-
tion sets, so providing us with an improved annotation set
already from source. The taxon restrictions are also used
by the UniProt-developed GO annotation curation inter-
face, Protein2GO [31], to prevent inappropriate manual
annotation from being created. Increasing numbers of GO
curators from the GOC, as well as some groups external
to the GOC, use Protein2GO, thus having quality control
mechanisms in place at the time an annotation is created
is important to these groups as it significantly reduces an-
notation errors.s four taxon restrictions, three of which are inherited from a parent term.
in taxonomic groups.
Figure 3 Inheritance of taxon restrictions. Less specific, parent terms have fewer taxon restrictions than more specific child terms that are
further down the hierarchy. This should be considered when choosing GO terms to use in automatic prediction methods. In the example shown,
predicting the term “fatty acid beta-oxidation multienzyme complex” for a set of multispecies proteins may result in more accurate annotation
than predicting the term “mitochondrial fatty acid beta-oxidation multienzyme complex”.
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with further annotation providers implementing taxon
constraints in their resource, this is expected to result in
increasing numbers of annotations being removed from
datasets giving a reduced, but more accurate, set of an-
notation predictions.Figure 4 Post-processing of automatic annotations. UniProt have rules
annotations, the annotation can be either deleted (row 1) or edited to use a m
annotated to “peroxisome”, these organelles are only present in cellular organ
annotated to “cytoplasm”, for viruses the correct GO term to use is “host cell c
describing this editing process is supplied with the annotation.Post-processing of annotations using taxon restrictions
In some cases, however, it is not always possible for the
annotation-providing group to refine their mappings be-
tween GO and another vocabulary to remove all of the
incorrect automatic predictions without an unacceptably
large loss of correct annotations. In these cases, UniProtin place such that if the taxon restrictions are violated in automatic
ore appropriate GO term (row 2). In row 1, an Entamoeba protein is
isms therefore the annotation is deleted. In row 2, a viral protein is
ytoplasm” therefore the GO term is substituted and a GO reference
Huntley et al. GigaScience 2014, 3:4 Page 8 of 9
http://www.gigasciencejournal.com/content/3/1/4has introduced additional measures to prevent certain
gene product-GO term combinations from being created
and these are described below.
Post-processing of annotations can ensure taxonomic
correctness of annotated GO terms using data supplied
by the GO taxon restrictions. An example of when this
post-processing can improve the accuracy of annotations
is again within the collaboration between UniProt and
InterPro. As described in the last section, mappings be-
tween InterPro identifiers and GO terms can be refined
so that predicted annotations are true for all proteins
matched. However, there can be exceptions where the pre-
dictions are not applicable to all the proteins matched, for
example when a small fraction of family members have
lost the active residues and are no longer catalytically ac-
tive. Removing the mappings between the InterPro identi-
fier and GO term in these cases would result in a large
number of valid annotations being deleted, so procedures
to handle the small number of inaccurate annotations are
invaluable. UniProt has mechanisms in place to automat-
ically handle annotations that fall into this category by
utilizing the GO taxon restrictions. Annotations can be ei-
ther deleted if no suitable alternative GO term can be
assigned, or edited to use a more appropriate GO term.
Two examples of this are shown in Figure 4. Firstly, an an-
notation to ‘peroxisome’ (GO:0005777) that is predicted
for a protein from the Entamoeba taxonomic group is de-
leted because this group of organisms do not have this
specific organelle. The second example is the prediction of
‘cytoplasm’ (GO:0005737) for viral proteins when the
more accurate term is ‘host cell cytoplasm’ (GO:0030430);
in this case the GO term is automatically substituted.
These updates are reflected in the GO reference that is
provided with the annotation.Annotation blacklist
The annotation blacklist allows us to specify which
protein:GO term combinations should not exist as an-
notations and it is populated from three sources: 1)
curator-review of automatic annotation pipelines, 2)
manually curated “caution” comments from UniProt that
indicate when a protein does not have the expected func-
tion, process or location and 3) NOT annotations pro-
vided to UniProtKB entries (annotations that explicitly
state a gene product is experimentally shown not to be as-
sociated with the annotated Biological Process, Molecular
Function or Cellular Component). The blacklist is used by
UniProt to prevent these annotations being created not
only by automatic annotation, but also by manual annota-
tion through the use of on-the-fly checks in our curation
interface, Protein2GO. The annotation blacklist is publicly
available as a webservice [32] and we welcome suggestions
for further additions.Conclusions
We have described here some examples of how the Gene
Ontology and its associated annotations can change over
time, using examples of how UniProt manages these
changes. It is of particular importance to those researchers
who make use of GO data for analysis to understand why
these changes occur in order to make the appropriate
conclusions for their interpretations. Additionally it is im-
portant for those who are generating GO annotation to
ensure they are using the most up-to-date and appropriate
terms. The GOC and the groups who provide GO annota-
tion are continually looking for ways to enhance both the
content of the GO and the GO annotations in order to
prevent this data from becoming stale, as well as to assist
researchers in forming hypotheses based on current and
accurate information.
Endnotes
aSearch of PubMed using the phrase “Gene Ontology”.
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